Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.8770
-0.0231 (-2.57%)
Feb 5, 2026, 10:00 AM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
Next-generation Cell and Gene Therapies
2.56M
Next-generation Cell and Gene Therapies Growth
-40.25%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
United States
2.56M
United States Growth
-40.25%